Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Elekta AB ( ($SE:EKTA.B) ) is now available.
Elekta AB held its Annual General Meeting on September 4, 2025, where several key resolutions were passed. The meeting approved a dividend payment, re-elected board members, and authorized share acquisitions and transfers. Additionally, a long-term performance-based share program for 2025 was adopted, focusing on shareholder return, hypofractionation installations, and CO2 reduction, indicating Elekta’s commitment to strategic growth and sustainability.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK34.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta AB is a company operating in the medical technology industry, primarily focusing on providing advanced solutions for cancer and brain disorder treatment. The company is known for its innovative products and services that cater to healthcare providers globally, aiming to improve patient care and outcomes.
Average Trading Volume: 1,001,792
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.55B
For a thorough assessment of EKTA.B stock, go to TipRanks’ Stock Analysis page.